Pacira BioSciences PCRX
NASDAQ PCRX
$25.21 +0.20 (+0.80%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pacira BioSciences (PCRX) Cost of Revenue (2010 - 2026)

Updated

Pacira BioSciences' Cost of Revenue was $44.16 million in Q2 2026, up 8.1% from $40.87 million a year earlier and up 21.3% from the prior quarter.

Analysis

Pacira BioSciences (PCRX) Cost of Revenue (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Pacira BioSciences' Cost of Revenue was $155.15 million through Jun 30, 2026, up 0.8% year-over-year; for FY2025, it was $149.75 million, down 12.1% from FY2024.

  • Cost of Revenue has now declined for three consecutive years, though with a five-year compound annual growth rate of 5.0% (FY2020 to FY2025).
  • In earlier years, Cost of Revenue was $170.43 million in FY2024 (-7.7%), $184.67 million in FY2023 (-7.3%), $199.3 million in FY2022 (+42.1%) and $140.26 million in FY2021 (+19.5%).
  • The Q2 2026 figure marks the highest quarterly Cost of Revenue since Q2 2024.
  • Compared with a year earlier, Cost of Revenue has increased for three straight quarters, with an average decline of 6.3% over the last eight quarters.
  • The best year-over-year quarter for Cost of Revenue over five years was Q4 2022 (growth of 58.7%); the worst was Q1 2025 (a decline of 27.6%).
  • Per Business Quant data, PCRX's Cost of Revenue in the three quarters before Q2 2026 was $36.41 million (Q1 2026), $40.3 million (Q4 2025) and $34.28 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Pacira BioSciences 1.00 Bn 65.95 Mn 148.24 Mn 44.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 44.16 Mn
Mar 31, 2026 36.41 Mn
Dec 31, 2025 40.30 Mn
Sep 30, 2025 34.28 Mn
Jun 30, 2025 40.87 Mn
Mar 31, 2025 34.31 Mn
Dec 31, 2024 39.89 Mn
Sep 30, 2024 38.86 Mn
Jun 30, 2024 44.26 Mn
Mar 31, 2024 47.42 Mn
Dec 31, 2023 47.69 Mn
Sep 30, 2023 39.75 Mn
Jun 30, 2023 48.21 Mn
Mar 31, 2023 49.02 Mn
Dec 31, 2022 61.92 Mn
Sep 30, 2022 50.68 Mn
Jun 30, 2022 50.63 Mn
Mar 31, 2022 36.07 Mn
Dec 31, 2021 39.01 Mn
Sep 30, 2021 34.65 Mn
API Access

Pacira BioSciences Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=PCRX&period=max&api_key=YOUR_API_KEY